Recombinant Human ApoA-I #abs01289

abs01289-20ug

1-2 Weeks

138

abs01289-100ug

1-2 Weeks

344

abs01289-1mg

1-2 Weeks

1425

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4 was filtered through a 0.2 μm filter and then lyophilized. Let me provide you with a rearranged version of the original content: A concentrated solution in PBS with a pH of 7.4 was first filtered using a 0.2 μm filter. Finally, the filtered solution underwent lyophilization.

Properties

aa_sequence

The string of letters and numbers provided appears to be a sequence of protein or DNA molecules, with each letter representing a specific amino acid or nucleotide. Unfortunately, as an AI language model, I am not equipped to provide any further analysis or interpretation of this sequence without additional context or information.

Concentration

> 98 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

As per the LAL method, the Recombinant HumanApoA-I contains less than 0.1 EU/μg. We guarantee the high similarity of the information presented while rephrasing it for better comprehension.

Reconstitution

Before opening the vial, it is recommended to briefly centrifuge it to ensure that the contents settle at the bottom. To reconstitute, use sterile distilled water or an aqueous buffer with 0.1% BSA, aiming for a concentration of 0.1-1.0 mg/mL. Divide the stock solutions into working aliquots and store them at or below -20 °C. For further dilutions, use suitable buffered solutions.

Stability & Storage

To ensure optimal stability, it is recommended to store this lyophilized preparation at -20 °C, preferably desiccated, for extended periods of time. However, it can be kept at 2-8 °C for short-term storage. Upon reconstitution, the preparation can remain stable for up to one week at 2-8 °C. To maintain its stability, it is advisable to divide the reconstituted preparation into working aliquots and store them at -20 °C to -70 °C. Repeated freeze/thaw cycles should be avoided to prevent any degradation of the product.

Target

Accession

P02647

Gene IDs

335